GABRIELLE WEYER: Open Payments
NPI 1790334704 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 9 payments from 5 companies in 2025. Trend: 2023 $1,010 · 2024 $904 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $314 |
| Novo Nordisk Inc | 1 | $124 |
| SANOFI US SERVICES INC. | 1 | $119 |
| GENZYME CORPORATION | 3 | $86 |
| Calliditas Therapeutics US Inc. | 1 | $28 |
Products named: KRYSTEXXA, Wegovy, FABRAZYME, TARPEYO.
Industry payments across LA — which companies pay providers there.
